Cost-Effectiveness of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the United States
Titel:
Cost-Effectiveness of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the United States
Auteur:
Carlson, Josh Foos, Volker Kasle, Adam Mugwagwa, Tendai Draica, Florin Lee Wiemken, Timothy Nguyen, Jennifer L. Cha-Silva, Ashley Migliaccio-Walle, Kristen Dzingina, Mendy
Verschenen in:
Value in health
Paginering:
Jaargang 27 () nr. 2 pagina's 164-172
Jaar:
2024
Inhoud:
Uitgever:
International Society for Pharmacoeconomics and Outcomes Research, Inc.